Application and progress of smart hydrogel microspheres for regulating oxidative stress in osteoarthritis
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 160620 - 160620
Published: Feb. 1, 2025
Language: Английский
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis
Cell Death and Differentiation,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 13, 2025
Abstract
The
plasma
concentrations
of
acyl
CoA
binding
protein
(ACBP)
encoded
by
the
gene
diazepam
inhibitor
(
DBI
)
are
increased
in
patients
with
severe
osteoarthritis
(OA).
Here,
we
show
that
knee
OA
induces
a
surge
ACBP/DBI
mice
subjected
to
surgical
destabilization
one
hind
limb.
Knockout
Dbi
or
intraperitoneal
(i.p.)
injection
monoclonal
antibody
(mAb)
neutralizing
attenuates
progression
this
model,
supporting
pathogenic
role
for
OA.
Furthermore,
anti-ACBP/DBI
mAb
was
also
effective
against
after
its
intraarticular
(i.a.)
injection,
as
monitored
sonography,
revealing
capacity
locally
reduce
inflammation
over
time.
In
addition,
i.a.
improved
functional
outcomes,
indicated
reduced
weight
imbalance
caused
At
anatomopathological
level,
mitigated
histological
signs
joint
destruction
and
synovial
inflammation.
Of
note,
blunted
OA-induced
ACBP/DBI,
well
other
inflammatory
factors
including
interleukin-1α,
interleukin-33,
tumor
necrosis
factor.
These
findings
potentially
translatable
because
joints
from
express
both
receptor
GABA
A
Rγ2.
Moreover,
novel
recognizing
an
epitope
conserved
between
human
mouse
demonstrated
similar
efficacy
mitigating
anti-mouse
ACBP/DBI-only
mAb.
conclusion,
might
constitute
promising
therapeutic
target
treatment
Language: Английский
Kojic acid alleviates osteoarthritis by attenuating inflammation and restoring impaired autophagy through regulating NF-κB and PI3K/AKT/mTOR signaling pathways: An in vivo and in vitro study
Junhong Li,
No information about this author
Guihua Yu,
No information about this author
Zhiyong He
No information about this author
et al.
International Immunopharmacology,
Journal Year:
2025,
Volume and Issue:
147, P. 114022 - 114022
Published: Jan. 6, 2025
Osteoarthritis
(OA)
is
the
most
prevalent
joint
disorder
globally,
causing
a
substantial
and
increasing
socioeconomic
burden.
Kojic
acid
(KA)
presented
potential
biological
roles
in
regulating
inflammation
autophagy,
which
was
implicated
OA
progression.
However,
its
role
chondrocytes
has
not
been
reported.
To
do
so,
this
study
aims
to
explore
chondroprotective
effect
of
KA
elucidate
regulatory
mechanisms.
IL-1β
vitro
used
induce
OA-like
phenotypes.
Cell
viability
measured
by
cell
counting
kit-8
assay.
RT-qPCR,
western
blotting,
as
well
immunofluorescence
staining
were
assess
protein
RNA
expression
inflammatory
(COX2
iNOS),
catabolic
(MMP13
MMP3),
anabolic
(collagen
II,
aggrecan
SOX9),
signaling
pathways
factors.
Destabilized
medial
meniscus
(DMM)
surgery
adopted
build
model
vivo.
After
consecutive
8
weeks
intra-articular
injection
KA,
X-ray,
μ-CT,
histological
staining,
immunohistochemistry
evaluate
effects
on
articular
cartilage
did
affect
chondrocyte
viability.
notably
elevated
factors
expression,
simultaneously,
inhibited
vitro.
Mechanistically,
significantly
suppressed
activated
NF-κB
PI3K/AKT/mTOR
pathways.
Moreover,
impaired
autophagy
restored
KA.
Inhibition
3-MA
diminished
Intra-articular
can
alleviate
DMM-induced
damage
Collectively,
our
work
first
demonstrate
that
osteoarthritis
attenuatinginflammationand
restoring
through
relevant
This
vivo
provides
strong
evidence
supportingKA
novel
valuable
approach
for
treating
OA.
Language: Английский
Mendelian randomization analysis to identify potential drug targets for osteoarthritis
Chenqi Lu,
No information about this author
Xu Yanan,
No information about this author
Shuai Chen
No information about this author
et al.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(2), P. e0316824 - e0316824
Published: Feb. 11, 2025
Background
Osteoarthritis
(OA)
is
a
prevalent
chronic
joint
disease
for
which
there
lack
of
effective
treatments.
In
this
study,
we
used
Mendelian
randomization
analysis
to
identify
circulating
proteins
that
are
causally
associated
with
OA-related
traits,
providing
important
insights
into
potential
drug
targets
OA.
Method
Causal
associations
between
1553
and
five
traits
were
assessed
in
large-scale
two-sample
MR
analyses
using
Wald
ratio
or
inverse
variance
weighting,
the
results
corrected
Bonferroni.
addition,
sensitivity
performed
validate
reliability
results,
including
reverse
Steiger
filtering
ensure
causal
direction
OA;
Bayesian
co-localization
phenotypic
scanning
eliminate
confounding
effects
horizontal
pleiotropy.
External
validation
was
exclude
incidental
findings
novel
plasma
protein
quantitative
trait
loci.
Finally,
online
tool
Enrichr
utilized
screen
drugs
molecular
docking
predict
binding
modes
energies
most
stable
likely
drugs.
Result
Four
ultimately
found
be
reliably
three
features:
DNAJB12
USP8
knee
OA,
IL12B
spinal
RGMB
thumb
The
ORs
above
1.51
(95%
CI,
1.26–1.81),
1.72
1.42–2.08),
0.87
0.81–0.92),
0.59
0.47–0.75),
respectively.
Drug-predicting
small
molecules
(doxazosin,
XEN
103,
montelukast)
simultaneously
target
proteins,
DNAJB12,
USP8,
IL12B,
docked
well.
Conclusion
Based
on
our
comprehensive
analysis,
can
draw
conclusion
relationship
genetic
levels
,
risk
respective
OA.They
may
options
OA
screening
prevention
clinical
practice.
They
also
serve
as
candidate
future
mechanism
exploration
selection.
Language: Английский
Aberrant anabolism hinders constructive metabolism of chondrocytes by pharmacotherapy in osteoarthritis
Bone and Joint Research,
Journal Year:
2025,
Volume and Issue:
14(3), P. 199 - 207
Published: March 5, 2025
Osteoarthritis
(OA)
is
a
highly
prevalent
and
disabling
disease
with
an
unmet
therapeutic
need.
The
characteristic
cartilage
loss
alteration
of
other
joint
structures
result
from
complex
interaction
multiple
risk
factors,
mechanical
overload
consistently
playing
central
role.
This
generates
inflammatory
response
in
the
due
to
activation
innate
immune
chondrocytes,
which
occurs
through
various
cellular
mechanisms.
Moreover,
factors
associated
obesity,
being
overweight,
metabolic
syndrome
enhance
both
locally
systemically.
OA
only
cells
present
articular
cartilage,
are
therefore
inflamed
initiate
anabolic
process
attempt
repair
damaged
tissue,
ultimately
results
aberrant
dysfunctional
process.
Under
these
circumstances,
where
continues
be
subjected
chronic
stress,
proposing
treatment
that
stimulates
chondrocytes'
restore
tissue
structure
does
not
appear
target
high
likelihood
success.
In
fact,
drugs
proposed
for
have
yet
demonstrate
efficacy.
By
contrast,
strategies
focused
on
pharmacologically
managing
component,
at
systemic
levels,
shown
promise.
Therefore,
prioritizing
control
pro-inflammatory
pathways
presents
most
viable
promising
strategy
effective
management
OA.
As
research
continues,
this
approach
may
offer
best
opportunity
alleviate
burden
incapacitating
disease.
Language: Английский
Research progress and prospect of MAPK signaling pathway in knee osteoarthritis
European Journal of Orthopaedic Surgery & Traumatology,
Journal Year:
2025,
Volume and Issue:
35(1)
Published: March 26, 2025
The
knee
joint,
one
of
the
most
vulnerable
joints
in
human
body,
is
susceptible
to
degenerative
changes
due
factors
such
as
aging,
obesity,
trauma,
inflammation,
and
genetic
predisposition.
These
contribute
primary
or
secondary
degeneration
joint
cartilage
bone
hyperplasia.
Knee
osteoarthritis
(KOA),
a
prevalent
condition
particularly
among
elderly,
significantly
impacts
patients'
quality
life.
Aberrant
activation
cellular
signaling
pathways,
namely
NF-κB,
MAPK,
Wnt
has
been
identified
key
factor
pathogenesis
KOA.
pathways
degradation,
disruption
anabolic-catabolic
balance
within
articular
cartilage.
Understanding
precise
roles
these
crucial
for
developing
targeted
therapies
prevent
treat
OA.
Therefore,
further
exploration
essential
develop
more
effective
therapeutic
strategies.
Language: Английский